| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.088 | 0.03 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.091 | 0.03 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.03 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.03 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.03 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |